Final Analysis Of Wsg-Adapt Her2+/Hr+ Phase-Ii-Trial - Efficacy, Safety And Predictive Markers For 12-Weeks Of Neoadjuvant T-Dm1 With Or Without Endocrine Therapy Versus Trastuzumab Plus Endocrine Therapy In Her2-Positive Hormone-Receptor-Positive Early Breast Cancer
ONCOLOGY RESEARCH AND TREATMENT（2016）
关键词
early breast cancer,breast cancer,endocrine therapy,wsg-adapt,phase-ii-trial,hormone-receptor-positive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要